Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmen Tur

Showing results (1-10 of 144) with videos related to

Pageof 15
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 24, 2021
Machine and deep learning in MS research are just powerful statistics - YesCarmen Tur
Current Treatment Options in Neurology|April 19, 2016
Fatigue Management in Multiple SclerosisCarmen Tur
Brain : a Journal of Neurology|May 28, 2026
High-efficacy therapy and progression independent of relapse and MRI activity in multiple sclerosisCarmen Tur
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 28, 2024
Progression independent of relapse activity in multiple sclerosis: Time to account for cognitive declineCarmen Tur, Emilio Portaccio
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 19, 2017
Progressive MS trials: Lessons learnedCarmen Tur, Xavier Montalban
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 3, 2014
Understanding the role of gender and hormones in multiple sclerosisMar Tintore, Carmen Tur
Expert Review of Clinical Immunology|August 14, 2012
Subcutaneous alemtuzumab for multiple sclerosisCarmen Tur, Xavier Montalban
CNS Drugs|June 20, 2014
Natalizumab: risk stratification of individual patients with multiple sclerosisCarmen Tur, Xavier Montalban
The Lancet. Neurology|December 15, 2023
Multiple sclerosis in 2023: beyond the boundariesCarmen Tur, Mar Tintoré
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 3, 2013
Possible new modifications for the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosisCarmen Tur, Xavier Montalban
Pageof 15

Showing results (1-10 of 144) with videos related to

Sort By:
Pageof 15
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 24, 2021
Machine and deep learning in MS research are just powerful statistics - YesCarmen Tur
Current Treatment Options in Neurology|April 19, 2016
Fatigue Management in Multiple SclerosisCarmen Tur
Brain : a Journal of Neurology|May 28, 2026
High-efficacy therapy and progression independent of relapse and MRI activity in multiple sclerosisCarmen Tur
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 28, 2024
Progression independent of relapse activity in multiple sclerosis: Time to account for cognitive declineCarmen Tur, Emilio Portaccio
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 19, 2017
Progressive MS trials: Lessons learnedCarmen Tur, Xavier Montalban
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 3, 2014
Understanding the role of gender and hormones in multiple sclerosisMar Tintore, Carmen Tur
Expert Review of Clinical Immunology|August 14, 2012
Subcutaneous alemtuzumab for multiple sclerosisCarmen Tur, Xavier Montalban
CNS Drugs|June 20, 2014
Natalizumab: risk stratification of individual patients with multiple sclerosisCarmen Tur, Xavier Montalban
The Lancet. Neurology|December 15, 2023
Multiple sclerosis in 2023: beyond the boundariesCarmen Tur, Mar Tintoré
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 3, 2013
Possible new modifications for the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosisCarmen Tur, Xavier Montalban
Pageof 15